在了解和管理质细胞瘤的进展
Kyung-Nam Koh1, Su Hyun Yoon2, Sung Han Kang2
1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. pedkkn@amc.seoul.kr.
Blood research
|July 4, 2024
概括
质细胞瘤,免疫细胞的罕见疾病,越来越多地通过遗传突变来理解. 像BRAF和MEK抑制剂这样的向疗法显示出希望,但需要进一步的研究才能获得最佳使用.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 囊性瘤是一种罕见的疾病,会影响巨细胞,树突细胞和单细胞.
- 这些包括兰格汉斯细胞囊细胞症 (LCH),埃尔德海姆-切斯特病 (ECD),罗莎-多夫曼病 (RDD),青少年桑托格兰瘤 (JXG) 和囊细胞肉瘤.
- 他们的多样化的临床课程需要对分类,流行病学和表现的深刻理解.
研究的目的:
- 审查当前对囊胞性瘤的理解.
- 详细介绍分子病理生理学,重点关注MAPK和PI3K-AKT通路.
- 讨论不断发展的治疗策略,特别是LCH,ECD,RDD和JXG.
主要方法:
- 审查当前关于质细胞瘤的文献.
- 对鉴定体质突变的遗传研究进行分析 (例如,BRAF,MAP2K1).
- 检查针对性治疗疗效和挑战的临床数据.
主要成果:
- 主要发生在MAPK路径中的体质突变,表明它具有克隆性瘤起源.
- 向疗法,包括BRAF抑制剂 (vemurafenib,dabrafenib) 和MEK抑制剂 (cobimetinib),已经显示出有效性.
- 挑战包括治疗后复发和不良影响,需要进一步研究.
结论:
- 分子遗传学和向治疗的进步已经改变了细胞瘤管理.
- BRAF和MEK抑制剂提供了新的治疗途径,特别是在高风险病例中.
- 持续的研究对于优化治疗持续时间,管理中断和改善患者的治疗结果至关重要.
关键词:
埃尔德海姆 - 切斯特病是什么?基因突变是一种基因突变.基质细胞性 基质细胞性青春期的桑托格兰瘤.朗格汉斯细胞的基细胞分裂新生体 新生体 新生体罗莎伊-多夫曼病 (Rosai-Dorfman disease) 是一种疾病.更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.3K
相关概念视频
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886